Clinical Trial Update: A Study to Compare Safety and Efficacy of Osmotic Release Oral Syytem (OROS) Hydromorphone Hydrochloride (HCl) With Morphine Sustain Release (SR) in Participants With Cancer Pain [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Osmotic Release Oral System hydromorphone hydrochloride with sustained-release morphine for cancer pain was terminated, with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Pain

Drugs mentioned

• Morphine Sulfate Sustained Release (morphine sulfate)
• Osmotic Release Oral System Hydromorphone Hydrochloride (hydromorphone hydrochloride)

Snippet

Sponsor: Johnson & Johnson Taiwan Ltd | Conditions: Cancer Pain | Phase 3 | Status: TERMINATED | Results posted: 2013-08-12